Dr. Shahrukh Hashmi is currently the Director of Research at the Department of Health, Abu Dhabi, UAE, and a Professor of Medicine at the Mayo Clinic Alix School of Medicine (Minnesota, US)
He graduated from Baqai Medical University, Pakistan, as the top graduate receiving Gold Medal from the President of Pakistan. He received Master’s Degree (MPH) from Yale University, Connecticut, US. He is triple-boarded from the US, being Diplomat of the American Board of Preventive Medicine/Public Health, Internal Medicine, and Hematology. He has served as PI or Co-PI on many industry-sponsored and NIH-sponsored trials. His research interests include premature Aging Biology, Artificial Intelligence, and Cellular therapies(CAR-T cells and Gene Therapy). He is also involved in Stem Cell Therapeutics, particularly in regenerative hematology. He has authored >300 articles in peer-reviewed journals, including in JAMA Oncology, Lancet Hematology, and NEJM, and has >10,000 citations.
He chairs many national or international professional committees/groups including being the Chair of the Worldwide Network for Blood and Marrow Transplant’s (WBMT) Global Emergencies Committee (Geneva, Switzerland), Founding Chair of the American Society for Transplantation and Cellular Therapy Survivorship SIG (Chicago, Illinois, US), and Ex Co-Chair of the Center for International Blood & Marrow Transplant Registry’s (CIBMTR) Health Services Committee (Milwaukee, Wisconsin, US). He is also a faculty at the Medical School of Khalifa University, UAE, and adjunct faculty at the Computer Vision Dept. at Mohamad Bin Zayed University of Artificial Intelligence, Abu Dhabi, UAE. He was Medi cal Director of Research at SSMC/Mayo Clinic (Abu Dhabi, UAE), and the Chairman of the Dept. of Hematology/Oncology at SSMC/Mayo Clinic.
His achievements include establishing the first BMT survivorship program of Mayo Clinic in Minnesota, establishing the first Clinical Trials Unit (Clinical Research Department) of Saudi Arabia at King Faisal Specialist Hospital & Research Center (KFSHRC) in Riyadh, KSA, and establishing the UAE’s first Clinical Trials Unit (CTU) at SSMC/Mayo Clinic in Abu Dhabi, UAE. He also utilized senolytics for First-in-Human Trials approved from the US-FDA and continues to serve as PI or Co-PI on Aging trials on Healthspan.
As an established scientist in Cell and Gene Therapy, along with Aging Biology and Artificial Intelligence, Dr. Hashmi is frequently invited to international forums to deliver plenary talks and has delivered >80 invited lectures/presentations at national and international forums. Dr. Hashmi is also active as a Board/Advisory Board Member of many organizations including Member of JV Clinical Board SSMC, Make A Wish Foundation UAE, Cancer Patient Care Society (Rahma) UAE, Emirates Thalassemia Society UAE, besides being the Associate Editor of JTCT (highest impact factor journal in the field of Cellular Therapies), and on Editorial Board member of numerous peer-reviewed journals.